loading
Precedente Chiudi:
$4.17
Aprire:
$4.17
Volume 24 ore:
20,603
Relative Volume:
0.03
Capitalizzazione di mercato:
$10.95M
Reddito:
$3.50M
Utile/perdita netta:
$-37.33M
Rapporto P/E:
-4.26
EPS:
-1
Flusso di cassa netto:
$-19.15M
1 W Prestazione:
+0.95%
1M Prestazione:
-36.42%
6M Prestazione:
-75.74%
1 anno Prestazione:
-82.82%
Intervallo 1D:
Value
$4.06
$4.3676
Intervallo di 1 settimana:
Value
$3.55
$5.47
Portata 52W:
Value
$3.55
$100.80

Hcw Biologics Inc Stock (HCWB) Company Profile

Name
Nome
Hcw Biologics Inc
Name
Telefono
954-842-2024
Name
Indirizzo
2929 N COMMERCE PKWY, MIRAMAR
Name
Dipendente
36
Name
Cinguettio
Name
Prossima data di guadagno
2025-04-01
Name
Ultimi documenti SEC
Name
HCWB's Discussions on Twitter

Confronta HCWB con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
HCWB
Hcw Biologics Inc
4.06 10.95M 3.50M -37.33M -19.15M -1.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
459.62 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.36 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
331.91 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
543.48 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.49 28.51B 3.81B -644.79M -669.77M -6.24

Hcw Biologics Inc Borsa (HCWB) Ultime notizie

pulisher
Jun 14, 2025

HCW Biologics (NASDAQ:HCWB) Rating Lowered to “Sell” at Wall Street Zen - Defense World

Jun 14, 2025
pulisher
Jun 13, 2025

HCW Biologics Sees Strong Investor Interest in June - TipRanks

Jun 13, 2025
pulisher
Jun 12, 2025

HCW Biologics Inc. (NASDAQ:HCWB) Short Interest Down 85.9% in May - Defense World

Jun 12, 2025
pulisher
Jun 10, 2025

HCW Biologics (NASDAQ:HCWB) Trading Down 7.6% – Here’s What Happened - Defense World

Jun 10, 2025
pulisher
Jun 08, 2025

Wall Street Zen Upgrades HCW Biologics (NASDAQ:HCWB) to “Hold” - Defense World

Jun 08, 2025
pulisher
Jun 05, 2025

HCW Biologics Meets Nasdaq Listing Requirements in May 2025 - TipRanks

Jun 05, 2025
pulisher
Jun 04, 2025

HCW Biologics partners with WY Biotech for immunotherapy By Investing.com - Investing.com South Africa

Jun 04, 2025
pulisher
Jun 04, 2025

HCW Biologics Secures Licensing Agreement with WY Biotech - TipRanks

Jun 04, 2025
pulisher
Jun 04, 2025

HCW Biologics partners with WY Biotech for immunotherapy - Investing.com Australia

Jun 04, 2025
pulisher
Jun 04, 2025

HCW Biologics (HCWB) Secures $7M Upfront License Fee in New Agreement with WY Biotech | HCWB Stock News - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

HCW Biologics Completes Deliverable and Solidifies License Agreement with WY Biotech - GlobeNewswire

Jun 04, 2025
pulisher
May 30, 2025

HCW Biologics Engages Armistice in Securities Purchase - TipRanks

May 30, 2025
pulisher
May 30, 2025

HCW Biologics (NASDAQ:HCWB) Price Target Lowered to $35.00 at Maxim Group - Defense World

May 30, 2025
pulisher
May 29, 2025

HCW Biologics (HCWB) Price Target Adjusted by Maxim | HCWB Stock News - GuruFocus

May 29, 2025
pulisher
May 29, 2025

HCWB: Maxim Group Maintains Buy Rating, Lowers Price Target | HC - GuruFocus

May 29, 2025
pulisher
May 29, 2025

HCWB: Maxim Group Maintains Buy Rating, Lowers Price Target | HCWB Stock News - GuruFocus

May 29, 2025
pulisher
May 23, 2025

HCW Biologics Issues Shares Through Warrant Exercise - TipRanks

May 23, 2025
pulisher
May 20, 2025

Insider Buying: Hing Wong Acquires Additional Shares of HCW Biol - GuruFocus

May 20, 2025
pulisher
May 20, 2025

HCW Biologics Enters Securities Purchase Agreement - TipRanks

May 20, 2025
pulisher
May 17, 2025

HCW Biologics (NASDAQ:HCWB) Trading 9.1% Higher – Still a Buy? - Defense World

May 17, 2025
pulisher
May 16, 2025

HCW Biologics Inc Reports Q1 2025 Earnings: Revenue at $5,065, Net Loss Reduced to $2.2 Million - GuruFocus

May 16, 2025
pulisher
May 15, 2025

HCW Biologics Reports First Quarter 2025 Business Highlights and Financial Results - The Manila Times

May 15, 2025
pulisher
May 15, 2025

HCW Biologics Inc. Reports Q1 2025 Financial Results and $5 Million Equity Offering Completion - Nasdaq

May 15, 2025
pulisher
May 15, 2025

HCW Biologics Closes $5 Million Public Offering - TipRanks

May 15, 2025
pulisher
May 14, 2025

HCW Biologics (HCWB) Launches $5M Follow-On Offering - GuruFocus

May 14, 2025
pulisher
May 14, 2025

HCW Biologics Announces Pricing of $5.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules - The Manila Times

May 14, 2025
pulisher
May 14, 2025

HCW Biologics Raises Fresh Capital: $5M Follow-On Offering Includes Attractive Warrant Package - Stock Titan

May 14, 2025
pulisher
May 13, 2025

HCWB Announces Maxim Group LLC as Sole Placement Agent for Offer - GuruFocus

May 13, 2025
pulisher
May 13, 2025

HCWB Announces Maxim Group LLC as Sole Placement Agent for Offering | HCWB Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Three layers of uncertainty - The Globe and Mail

May 13, 2025
pulisher
May 13, 2025

Nasdaq Rises Over 1%; Under Armour Posts Strong Q4 Sales - Benzinga

May 13, 2025
pulisher
May 13, 2025

Trading Halt for HCW Biologics (HCWB) Due to Volatility | HCWB S - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Trading Resumes for HCW Biologics (HCWB) | HCWB Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

HCW Biologics Reports Positive Results For HCW9206 And Opens Commercial Partnership Talks - Nasdaq

May 13, 2025
pulisher
May 13, 2025

HCW Biologics Says Studies Show HCW9206 Fusion Protein Addresses Key Challenges for CAR-T Therapies; Shares Surge - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

HCW Biologics (HCWB) Unveils Innovative Pathway for Enhanced CAR - GuruFocus

May 13, 2025
pulisher
May 13, 2025

HCW Biologics presents novel CAR-T cell enhancer By Investing.com - Investing.com Nigeria

May 13, 2025
pulisher
May 13, 2025

HCW Biologics presents novel CAR-T cell enhancer - Investing.com

May 13, 2025
pulisher
May 13, 2025

HCW Biologics Announces Positive Results of Studies of - GlobeNewswire

May 13, 2025
pulisher
May 13, 2025

HCW Biologics Announces Positive Results of Studies of Proprietary Compound, HCW9206 and Availability for Commercialization - TradingView

May 13, 2025
pulisher
May 12, 2025

Friday’s Insider Moves: Top Buys and Sells in US Stocks Revealed By Investing.com - Investing.com South Africa

May 12, 2025
pulisher
May 12, 2025

Friday’s Insider Moves: Top Buys and Sells in US Stocks Revealed - Investing.com

May 12, 2025
pulisher
May 11, 2025

Prediction: Warren Buffett May Be Shifting Out of His Berkshire Hathaway CEO Role, but He's Not Done Investing - The Globe and Mail

May 11, 2025
pulisher
May 11, 2025

Should You Buy Rivian Stock While It Is Still Below $15? - The Globe and Mail

May 11, 2025
pulisher
May 10, 2025

This Well-Known Toy Company Is Set to Be an Outperformer if the Tariff War Continues - The Globe and Mail

May 10, 2025
pulisher
May 10, 2025

Insider Buying: Gary Winer Acquires Shares of HCW Biologics Inc (HCWB) - GuruFocus

May 10, 2025
pulisher
May 09, 2025

Hcw biologics CEO acquires $2.41 million in stock By Investing.com - Investing.com Nigeria

May 09, 2025

Hcw Biologics Inc Azioni (HCWB) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Hcw Biologics Inc Azioni (HCWB) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Winer Gary M
Director
May 16 '25
Buy
7.45
1,342
9,998
4,075
GARRETT SCOTT T
Director
May 16 '25
Buy
7.45
13,423
100,001
25,505
Winer Gary M
Director
May 08 '25
Buy
26.00
2,308
60,008
2,733
Wong Hing C
Chief Executive Officer
May 08 '25
Buy
26.00
92,500
2,405,000
493,857
GARRETT SCOTT T
Director
May 08 '25
Buy
26.00
5,385
140,010
12,082
Byam Rebecca
Chief Financial Officer
May 08 '25
Buy
26.00
8,462
220,012
43,010
Flowers Lee
SVP of Business Development
May 08 '25
Buy
26.00
962
25,012
5,720
Greene Rick S.
Director
May 08 '25
Buy
26.00
962
25,012
2,066
$20.39
price down icon 0.34%
$36.24
price down icon 0.27%
$23.15
price up icon 7.69%
$96.83
price down icon 0.40%
$108.13
price up icon 0.15%
biotechnology ONC
$247.47
price up icon 1.13%
Capitalizzazione:     |  Volume (24 ore):